Avalon与达安基因合作开展液体活检诊断

AvalonGloboCare公司近日表示，已经与达安基因达成战略合作关系，进一步优化Avalon的外泌体技术临床开发和产品商业化。

Avalon表示，作为合作的一部分，它将联合达安基因的资源加速基于外泌体的体外诊断产品的开发和商业化。达安基因拥有荧光定量PCR诊断试剂专有核心技术平台的知识产权。

Avalon指出，达安基因已同意优先使用和购买Avalon及其子公司GenExosome Technologies的技术和产品。Avalon表示，此次合作将促进分子病理学和再生医学的生物医学创新和临床进展，并利用中山大学医学院和附属医院的转化研究。

Avalon公司总裁兼首席执行官David Jin在一份声明中表示，与达安基因的战略合作“将显著加速我们在液体活检和体外诊断领域的产品开发和商业化。”他指出，合作将把达安的基因组测序和分析平台与Avalon专有的外泌体分离系统和再生医学的临床专长结合起来。

Avalon GloboCare said today that it has entered a strategic partnershipwith Da An Gene to "further optimize" Avalon's exosome technology,clinical development, and product commercialization.

Freehold, New Jersey-based Avalon said that as part of the collaboration,it will unite resources with Da An Gene to accelerate exosome-based in vitrodiagnostic product development and commercialization. Da An Gene has intellectualproperty rights covering its proprietary core technology platform offluorescent-quantitative PCR diagnostic reagents, Avalon said.

Avalon noted that Da An Gene — part of Sun Yat-sen UniversitySchool of Medicine in Guangzhou, China — has agreed to prioritize the use and purchase oftechnologies and products of Avalon and of its subsidiary GenExosomeTechnologies. Avalon said that the partnership will promote and fosterbiomedical innovation and clinical advances in molecular pathology and regenerativemedicine and take advantage of translational research at Sun Yat-sen UniversitySchool of Medicine and affiliated hospitals.

Additional terms of the agreement were not disclosed.

David Jin, president and CEO of Avalon GloboCare, said in a statement thatthe strategic partnership with Da An Gene "will significantly accelerateour product development and commercialization in the fields of liquid biopsyand in vitro diagnostics." He noted that the partners would combine DaAn's genomic sequencing and profiling platform with Avalon's proprietaryexosome isolation system and clinical expertise in regenerative medicine.

Da An Gene participates in product research, development, commercialization,and application in the molecular diagnostics sector in China. Its researchinstitutes in China include the Medical Biotechnology Research Center under theMinistry of Health; the Clinical Medical Molecular Diagnostic EngineeringLaboratory of Guangdong Province; and Guangzhou Antibody Engineering TechnologyResearch Center. 

编辑：Weber